Kerala Ayurveda

Kerala Ayurveda Ltd.

BSE: 530163 SECTOR: Pharmaceuticals & Drugs  13k   27   1

120.00
+1.65 (1.39%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 120.9

Today's Low

₹ 116.8

52 Week High

₹ 144.75

52 Week Low

₹ 0

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 126.67 Cr.

Enterprise Value

₹ 187.93 Cr.

No. of Shares

1.06 Cr.

P/E

42.68

P/B

12.05

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  9.96

CASH

₹ 0.13 Cr.

DEBT

₹ 61.39 Cr.

Promoter Holding

61.52 %

EPS (TTM)

₹  2.81

Sales Growth

29.16%

ROE

11.64 %

ROCE

10.19%

Profit Growth

117.97 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year29.16%
3 Year6.27%
5 Year7.09%

Profit Growth

1 Year117.97%
3 Year-9.47%
5 Year-16.59%

ROE%

1 Year11.64%
3 Year-11.47%
5 Year-2.51%

ROCE %

1 Year10.19%
3 Year4.43%
5 Year5.08%

Debt/Equity

7.4345

Price to Cash Flow

14.47

Interest Cover Ratio

1.20463058106003

CFO/PAT (5 Yr. Avg.)

34.9636412738549

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 61.52 100
Dec 2022 61.52 100
Sep 2022 61.52 0
Jun 2022 61.52 100
Mar 2022 61.52 100
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.361768619450825.
  • The company has an efficient Cash Conversion Cycle of -19.5367865332209 days.
  • The company has a good cash flow management; CFO/PAT stands at 34.9636412738549.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 21.3793315475611.

 Limitations

  • The company has shown a poor profit growth of -9.46578640588798% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.27299273453779% for the Past 3 years.
  • Company has a poor ROE of -11.4667255614717% over the past 3 years.
  • Promoter pledging has increased from 61.52% to 100% in 1 quarter.
  • Company has a poor ROCE of 4.42908614816303% over the past 3 years
  • Company has high Debt to Equity ratio of 7.4345.
  • The company is trading at a high PE of 42.68.
  • Promoter pledging is high as 100%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 13.24 14.2 12.83 15.9 15.3
Total Expenditure 11.52 11.84 11.72 13.62 14.8
Operating Profit 1.73 2.36 1.11 2.28 0.51
Other Income 0.07 0.09 0.02 0.01 0.02
Interest 1.45 1.22 1.17 1.04 1.07
Depreciation 0.2 0.2 0.17 0.17 0.18
Exceptional Items 0 0 0 0 2.84
Profit Before Tax 0.16 1.04 -0.22 1.08 2.11
Tax 0.04 0.3 -0.06 0.27 0.53
Profit After Tax 0.12 0.74 -0.16 0.81 1.58
Adjusted EPS (Rs) 0.11 0.7 -0.15 0.76 1.5

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 43.77 46.49 53.68 43.2 55.8
Total Expenditure 38.1 43.49 50.58 43 48.07
Operating Profit 5.66 3 3.11 0.21 7.73
Other Income 0.26 0.26 0.16 0.17 0.3
Interest 2.02 2.23 1.37 6.14 6.03
Depreciation 0.51 0.56 0.68 0.82 0.77
Exceptional Items 0 1.28 0 0 0
Profit Before Tax 3.4 1.75 1.22 -6.58 1.23
Tax 1.1 0.55 0.34 -1.63 0.35
Net Profit 2.3 1.2 0.88 -4.95 0.89
Adjusted EPS (Rs.) 2.18 1.14 0.83 -4.69 0.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 10.56 10.56 10.56 10.56 10.56
Total Reserves 7.12 2.94 4.11 -0.51 0.72
Borrowings 38.74 45.08 47.16 47.85 28.76
Other N/C liabilities 4.43 8.83 9.49 7.83 4.16
Current liabilities 39.16 19.76 22.28 29.79 47.13
Total Liabilities 100.01 87.16 93.6 95.51 91.33
Assets
Net Block 16.49 16.62 17.09 16.8 27.96
Capital WIP 8.65 9.94 11.55 11.98 2.34
Intangible WIP 0 0 0 0 0
Investments 11.47 11.47 11.47 11.37 11.37
Loans & Advances 20.34 21.32 23.03 24.5 22.07
Other N/C Assets 0.35 0.37 3.08 3.07 4.19
Current Assets 42.72 27.44 27.38 27.8 23.39
Total Assets 100.01 87.16 93.6 95.51 91.33
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 3.4 3.83 2.44 -0.53 7.12
Adjustment 2.35 -6.35 0.82 0.97 0.81
Changes in Assets & Liabilities -16.62 12.5 1.45 -1.35 0.82
Tax Paid 0 -0.64 0 0 0
Operating Cash Flow -10.87 9.34 4.71 -0.91 8.75
Investing Cash Flow -2.2 -1.7 -3.93 -2.1 0.83
Financing Cash Flow 16.05 -11.14 0.29 2.18 -10.52
Net Cash Flow 2.98 -3.5 1.06 -0.83 -0.94

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 61.52 61.52 61.52 61.52 61.52
katra holdings ltd 61.52 61.52 61.52 61.52 61.52
katra holdings lim... - - - - -
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 38.48 38.48 38.48 38.48 38.48
shon randhawa 4.71 4.71 4.71 4.71 4.71
porinju veliyath 2.37 2.37 2.37 1.89 1.89
shree varma - - - - -
dheeraj kumar lohia - - - - 2.05
anil kumar k - 1.90 1.90 1.90 1.90
anilkumar kunjupan... 1.90 - - - -
shree varma bio na... 1.89 1.71 - 1.42 -
sree varaham bio n... - - 1.71 - -
sashikanth balacha... 1.44 - - - -
b. sashikanth - 1.40 - 1.30 -
b sasikanth - - 1.40 - -
raghavendra raju... - 1.13 - - -
raghavendra raju m... 1.13 - - - -
raghavendra raju ... - - - - -
raghavendra raju m... - - 1.09 - -
marging trading ac... - - 0.01 - -
margin trading acc... - - - 0.01 -
margin trading acc... - - - - 0.01

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Kerala Ayurveda Stock Price Analysis and Quick Research Report. Is Kerala Ayurveda an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kerala Ayurveda and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 8.7531 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kerala Ayurveda has a Debt to Equity ratio of 7.4345 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kerala Ayurveda , the EPS growth was 117.968400179108 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kerala Ayurveda has OPM of 13.8530908204613 % which is a bad sign for profitability.
     
  • ROE: Kerala Ayurveda have a average ROE of 11.6420606250982 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Kerala Ayurveda

X